Shanxi C&Y Pharmaceutical Group Co.Ltd(300254) : Announcement on subsidiaries' obtaining industrial development support funds

Securities code: 300254 securities abbreviation: Shanxi C&Y Pharmaceutical Group Co.Ltd(300254) Announcement No.: 2022-001 Shanxi C&Y Pharmaceutical Group Co.Ltd(300254)

Announcement on subsidiaries' obtaining industrial development support funds

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.

1、 Basic information of obtaining industrial development support funds

Tibet Qianyuan Pharmaceutical Co., Ltd. (hereinafter referred to as "Tibet Qianyuan"), a subsidiary of Shanxi C&Y Pharmaceutical Group Co.Ltd(300254) (hereinafter referred to as "the company"), recently received 5 million yuan of industrial development support fund allocated to Tibet Qianyuan by the Management Committee of Tibetan Youth Industrial Park of Tibet Autonomous Region. The details are as follows:

Whether the government subsidy is obtained and whether it accounts for the amount of the recent government subsidy. The basis for the daily subsidy received is that the subsidy has a period of audited net items in the main form of time business activity type (10000 yuan) Proportion of related continuing assets

Tibet Autonomy

200 cash in 2022 zone 1 Tibetan Youth industry

June 19 Park Management Committee

Industry Development Council drugs and medical and income

Tibet exhibition support is the benefit of medical equipment trade, which is the business cooperation of enterprises with 0.73% Qianyuan capital

Signing agreement

300 cash reserves in January 2022 (2020)

On June 20, Qingyuan Yaojing Investment Co., Ltd

Zi No. 11

2、 Types of industrial development support funds and their impact on Listed Companies

1. Types of government subsidy funds

According to the provisions of the accounting standards for Business Enterprises No. 16 - government subsidies, the government subsidies related to assets refer to the government subsidies obtained by the enterprise for the purchase and construction or the formation of long-term assets in other ways; Government subsidies related to income refer to government subsidies other than those related to assets. The government subsidies obtained by the above companies are not used for the purchase and construction of long-term assets or other forms, so they are income related government subsidies. 2. Recognition and measurement of subsidies

According to the accounting standards for Business Enterprises No. 16 - government subsidies, the above subsidies are income related government subsidies, which will be directly included in the current profit and loss. It is estimated that the impact of the above subsidies on the company's profit and loss in 2022 is 5 million yuan.

3. Impact of subsidies on the company

The company will reasonably and legally use the government subsidy funds in accordance with relevant laws and regulations and the requirements of relevant government departments to realize the efficient use of government subsidy funds.

3、 Risk tips and other instructions

The above data has not been audited. The specific accounting treatment and its impact on the relevant financial data of the company shall be subject to the results confirmed by the accounting firm. Investors are reminded to pay attention to investment risks.

It is hereby announced

Shanxi C&Y Pharmaceutical Group Co.Ltd(300254) board of directors

January 24, 2002

- Advertisment -